These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 16905016)

  • 1. Who controls the controllers?
    Ikenberg H
    Lancet; 2006 Aug; 368(9535):578-9; author reply 579. PubMed ID: 16905016
    [No Abstract]   [Full Text] [Related]  

  • 2. Human papillomavirus and cervical cancer screening. Recent advances improve the clinical picture.
    Berman NR
    Adv Nurse Pract; 2002 Oct; 10(10):26-35; quiz 35-6. PubMed ID: 12424881
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical practice. Cervical-cancer screening with human papillomavirus and cytologic cotesting.
    Schiffman M; Solomon D
    N Engl J Med; 2013 Dec; 369(24):2324-31. PubMed ID: 24328466
    [No Abstract]   [Full Text] [Related]  

  • 4. Novaprep(®) Vial Test is a suitable liquid-based cytology medium for high risk human papillomavirus testing by Hybrid Capture 2.
    Prétet JL; Vidal C; Le Bail Carval K; Ramanah R; Carcopino X; Cartier I; Labouyrie E; Kantelip B; Coumes-Marquet S; Riethmuller D; Mougin C
    J Clin Virol; 2010 Dec; 49(4):286-9. PubMed ID: 20884288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening by cytology and human papillomavirus testing during pregnancy in French women with poor adhesion to regular cervical screening.
    Brun-Micaleff E; Coffy A; Rey V; Didelot MN; Combecal J; Doutre S; Daurès JP; Segondy M; Boulle N
    J Med Virol; 2014 Mar; 86(3):536-45. PubMed ID: 24114972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cancer screening: Less testing, smarter testing.
    Jin XW; Sikon A; Yen-Lieberman B
    Cleve Clin J Med; 2011 Nov; 78(11):737-47. PubMed ID: 22049541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of cytopathology in Europe. Will the wider use of HPV testing have an impact on the provision of cervical screening?
    Gray W; Bayer-Pietsch E; Chieco P; Cochand Priollet B; Desai M; Drijkoningen M; Griffin M; Hagmar B; Kapila K; Kloboves-Prevodnik V; Kobayashi T; Krogerus L; Majak B; Mihailovici M; Olszewski W; Schenck U; Schmitt F; Shabalova I; Shapiro N; Smith J; Tani E; Totsch M; Vass L; Wiener H; Herbert A
    Cytopathology; 2007 Oct; 18(5):278-82. PubMed ID: 17883689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the HPV MLPA assay in cervical cytology for the prediction of high grade lesions.
    Litjens RJ; Theelen W; van de Pas Y; Ossel J; Reijans M; Simons G; Speel EJ; Slangen BF; Ramaekers FC; Kruitwagen RF; Hopman AH
    J Med Virol; 2013 Aug; 85(8):1386-93. PubMed ID: 23765775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is HPV testing with cytological triage a more logical approach in cervical cancer screening?
    Franco EL; Ferenczy A
    Lancet Oncol; 2006 Jul; 7(7):527-9. PubMed ID: 16814203
    [No Abstract]   [Full Text] [Related]  

  • 10. [HPV-tests as suitable complement to cytological screening].
    Rubinstein E
    Lakartidningen; 1999 May; 96(18):2195. PubMed ID: 10377654
    [No Abstract]   [Full Text] [Related]  

  • 11. Overview of the cytology laboratory: specimen processing through diagnosis.
    Joste N
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):549-63; viii. PubMed ID: 19061816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European consensus statement on "HPV Vaccination and Colposcopy".
    Shafi MI; Petry U; Bosch XF; Gissman L; Kocken M; Helmerhorst TJ; Stanley M; Nazeer S; European Federation for Colposcopy
    J Low Genit Tract Dis; 2011 Oct; 15(4):309-15. PubMed ID: 21959574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Has cytology become obsolete as a primary test in screening for cervical cancer?
    Rebolj M; Lynge E
    J Med Screen; 2010; 17(1):1-2. PubMed ID: 20356936
    [No Abstract]   [Full Text] [Related]  

  • 14. Liquid-based versus conventional cervical cytology.
    Boon ME
    Lancet; 2006 May; 367(9521):1482; author reply 1482-3. PubMed ID: 16679153
    [No Abstract]   [Full Text] [Related]  

  • 15. Cervical cytology screening in HIV-positive women: do samples from genitourinary medicine departments have high inadequacy rates?
    Sundaram SS; Vijeratnam D; Patel R; Samraj S
    Int J STD AIDS; 2012 Mar; 23(3):227. PubMed ID: 22581887
    [No Abstract]   [Full Text] [Related]  

  • 16. Has cytology become obsolete as a primary test in screening for cervical cancer?
    Sasieni P
    J Med Screen; 2010; 17(1):2-3. PubMed ID: 20356937
    [No Abstract]   [Full Text] [Related]  

  • 17. Why do we go on screening?
    Marsan C
    Pol J Pathol; 2005; 56(4):167-9. PubMed ID: 16477875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Papillomavirus, uterine cervix cancer and screening].
    Philip J
    Ugeskr Laeger; 1998 Dec; 160(50):7275. PubMed ID: 9859731
    [No Abstract]   [Full Text] [Related]  

  • 19. Human papillomavirus and cervical disease in adolescents.
    Guido R
    Clin Obstet Gynecol; 2008 Jun; 51(2):290-305. PubMed ID: 18463460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choosing a screening method for cervical cancer: Papanicolaou testing alone or with human papillomavirus testing.
    Smith-McCune K
    JAMA Intern Med; 2014 Jul; 174(7):1027-8. PubMed ID: 24796546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.